Pernix Therapeutics Holdings News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.10.16	Watch Out For CTRV, FDA Delays Decision On EGLT, OGXI In Low Spirits (RTTNews)
15.05.15	Pre-market Movers For May 15 (NFLX, AMAT, JWN, BSQR, PTX, AVP, KING, GMCR) (RTTNews)
15.05.15	Pernix Therapeutics : FDA Oks TREXIMET For Use In Pediatric Patients (RTTNews)
10.03.15	Zogenix To Sell Zohydro ER Business To Pernix For $100 Mln. Plus Milestones (RTTNews)
26.02.15	AMGN Study Meets Goal, BRLI Hits New High, DPRX On Watch, GMED Opens Wallet (RTTNews)
16.01.15	PIP Awarded $195M, DEPO Expands Pain Management Portfolio, CRMD On Fast Track (RTTNews)
23.06.14	Pernix Therapeutics Appoints Sanjay Patel As CFO (RTTNews)
14.05.14	PERNIX To Buy TREXIMET® Tablets For Migraine From GSK - Quick Facts (RTTNews)
01.04.14	Pernix Therapeutics To Divest Pernix Manufacturing To Woodfield Pharma (RTTNews)
17.03.14	Pernix Therapeutics Q4 Loss Widens (RTTNews)
10.03.14	Pernix Therapeutics Appoints Terence Novak As COO (RTTNews)
05.02.14	Pernix Therapeutics Names Doug Drysdale CEO; Settles Pending Legal Liabilities (RTTNews)
12.11.13	Pernix Therapeutics Holdings Q3 Loss Widens; Cuts FY13 Revenue Range (RTTNews)
15.05.12	Pernix Therapeutics Reports First Quarter 2012 Financial Results (Businesswire)
09.05.12	Pernix Therapeutics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference (Businesswire)
07.05.12	Pernix Therapeutics to Report First Quarter 2012 Financial Results on May 15, 2012 (Businesswire)
26.04.12	Pernix Therapeutics Completes At-the-Market Equity Offering (Businesswire)
29.03.12	Pernix Therapeutics to Present at the 11th Annual Needham Healthcare Conference (Businesswire)
28.03.12	Pernix Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results (Businesswire)
20.03.12	Pernix Therapeutics to Report Fourth Quarter and Full Year 2011 Financial Results on March 28, 2012 (Businesswire)
07.03.12	Pernix Therapeutics Provides Business Update and Announces New Product Development Agreement (Businesswire)
06.03.12	Pernix Therapeutics to Present at the 24th Annual ROTH Conference (Businesswire)
28.02.12	Pernix Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference (Businesswire)
23.01.12	Pernix Therapeutics Announces Agreement to License a New FDA-Approved Product to Treat Gastroenterology Disease (Businesswire)
06.12.11	Pernix Therapeutics Expands Senior Management Team to Support Continued Business Growth (Businesswire)
21.11.11	Pernix Therapeutics to Present at the Piper Jaffray 23rd Annual Health Care Conference (Businesswire)
15.11.11	Pernix Therapeutics Holdings Reports Third Quarter 2011 Financial Results (Businesswire)
12.01.11	Multiple Myeloma Research Foundation (MMRF) and Synta Pharmaceuticals Enter into Joint Collaboration to Accelerate Drug Development for Myeloma Patients (Businesswire)
12.08.10	Willdan Reports Second Quarter 2010 Financial Results (Businesswire)
17.11.08	CORRECTING and REPLACING Golf Trust of America, Inc. Announces Stock Repurchase Program (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Swiss Life Hldg	812.40	0.45 %	K V
Geberit	552.80	0.36 %	K V
Swisscom	513.50	0.20 %	K V
Logitech Intl	75.48	0.13 %	K V
Givaudan	3’825.00	0.05 %	K V
Part Grp Hldg	1’246.00	-1.35 %	K V
Novartis	96.82	-1.63 %	K V
Sonova Hldg	252.10	-1.68 %	K V
Lonza Grp	532.00	-1.77 %	K V
Roche Hldg G	286.80	-1.92 %	K V

Pernix Therapeutics Holdings Aktie VALOR 11104290 / ISIN US71426V1089

Nachrichten zu Pernix Therapeutics Holdings Inc

Aktien Top/Flop

Meistgelesene Nachrichten